To clarify the possible pathogenetic role of oxidation products originated from the glycation of proteins, human globins from nephropathic patients have been studied by matrix-assisted laser desorption/ionization mass spectrometry (MALDI), revealing not only unglycated and monoglycated globins, but also a series of different species. For the last ones, structural assignments were tentatively done on the basis of observed masses and expectations for the Maillard reaction pattern. Consequently, they must be considered only propositive, and the discussion which will follow must be considered in this view. In our opinion this approach does not seem to compromise the intended diagnostic use of the data because distinctions are valid even if the assignments are uncertain. We studied nine healthy subjects and 19 nephropathic patients and processed the data obtained from the MALDI spectra using a multivariate analysis. Our results showed that multivariate analytical techniques enable differential aspects of the profile of molecular species to be identified in the blood of end stage nephropathic patients. A correct grouping can be achieved by principal component analysis (PCA) and the results suggest that several products involved in carbonyl stress exist in nephropathic patients. These compounds may have a relevant role as specific markers of the pathological state. (J Am Soc Mass Spectrom 2007, 18, 1018 -1023 
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It is generally believed that these products originate from glycated proteins via mechanisms generally involving the classic Maillard reaction pattern [10 -13] : the hexose molecules react with the amino group that is either terminal or exposed in the protein structure, undergoing a series of dehydration and oxidation reactions that ultimately lead to the release of reactive dicarbonyls.
End-stage renal disease can be the outcome of many different kidney pathologies and is characterized by severe kidney function impairment. Some pathological events in end-stage renal disease are the consequences of an accumulation in the plasma of the so-called uremic toxins, the nature of which has yet to be fully clarified. Among these products, the activity of carbonyl compounds has recently been emphasized, and this topic has been an object of many investigations [1, 2, 5, 14, 15] .
Carbonyl compounds, due to their high reactivity, are believed to be responsible for various types of tissue damage related to several conditions characteristic of end-stage disease, e.g., macroangiopathy, dialysis-related amyloidosis, and myocardial damage [6, 7, 16 -18] . I n nonpathological states, these compounds are usually excreted by the kidney, but in the case of severe kidney disease their excretion is impaired, leading to what is called "carbonyl stress" [10, 19 -23] .
Previous investigations of human globins performed by MALDI mass spectrometry [24 -29] were devoted mainly to ascertaining the significance of glycated hemoglobin (HbA 1c ), a specific subtype of hemoglobin A, formed by the binding of glucose to the hemoglobin molecule. Since HbA 1c degradation proceeds relatively slowly, the blood level of HbA 1c represents the average blood glucose levels of about the past four weeks. The amount of this glycated hemoglobin is used in clinics as an indicator of the average glucose blood levels, and may also suggest the amount of glycation-linked damage to tissues. MALDI mass spectrometry showed that many globin species are expressed by healthy and diabetic subjects [26 -29] . Apart from the peaks related to unglycated and monoglycated ␣and ␤-globins, numerous other different ionic species were identified by MALDI MS, including some glycoxidation products, reflecting the subject's oxidative stress. These studies also proved that the HbA 1c values, usually evaluated by HPLC methods or with electrospray mass spectrometric methods (LC/ESI/MS), [30] are not linearly related with the ␤-globin glycation level (as is generally assumed), but do correlate well with the whole pool of glycated and glycoxidated species detected by MALDI/MS [28, 29] .
To clarify the question whether of oxidation products originated from the glycation of proteins survive on the protein frame or, once formed, are released from the protein, leading to the production of dicarbonyl compounds, we thought it may be of interest to evaluate the level of these substances in blood samples. Hence, our interest in the analytical data obtained by MALDI for a series of blood samples from nephropathic subjects, which we compared with the data obtained in healthy controls.
Materials and Methods

Subjects
Nineteen patients with chronic renal failure and nine normal controls were evaluated. Their clinical and metabolic characteristics are shown in Table 1 . Ten of the nephropathic patients were on hemodialysis and nine were on peritoneal dialysis. All patients had been in stable clinical condition for six months before the study. Exclusion criteria were: malnutrition, smoking, Were evaluated by standard clinical analysis.
diabetes mellitus, neoplasia, and chronic inflammatory diseases. All subjects gave their informed consent to the study, which was approved by the local Ethics Committee and was conducted in accordance with the Helsinki Declaration of 1975.
Methods
Fresh blood samples were diluted 1:50 in water and frozen until MALDI analysis. The samples were then diluted 1:10 with a 0.1% trifluoroacetic acid aqueous solution. The matrix solution was prepared by dissolving 10 mg of 2,6-dihydroxyacetophenone (DHAP) (Fluka, Buchs, CH) in 1 mL of 1:1 (vol/vol) ethanol/ acetonitrile with the addition of 100 L of 1M aqueous solution of diammonium hydrogen citrate (DHAC) (Fluka). These solutions were vortexed before use. Samples were prepared by mixing equal volumes of matrix and sample solutions, applying 1 L to a stainless steel sample holder and allowing it to dry before mass spectrometric analysis. MALDI spectra were obtained on a Voyager-DE PRO instrument (Applied Biosystems, Foster City, CA), working in positive linear mode. The target was irradiated with a 337 nm pulsed nitrogen laser. Ions were accelerated to 25.0 keV kinetic energy. The working conditions for the extraction delay were: grid voltage 92%; guide wire ϭ 0.15%; extraction delay time ϭ 300 ns. Mass spectra were obtained by averaging 50 laser shots; three separate MALDI measurements were taken for each sample to establish their reproducibility.
Data Treatment and Statistical Analysis
MALDI-MS data in the range 15 to 16.4 kDa on the whole-blood samples of patients and healthy controls were inserted into a spreadsheet and sorted by m/z values. The abundance of the different compounds arising from glycation and glyco-oxidation processes of ␣and ␤-globins, whose identification and structures have been assigned on the basis of the Maillard reaction pattern, have been expressed as relative abundance of the corresponding globin peak, kept equal to 100. The renormalization of the spectrum so obtained has a chemical meaning; in fact ␣and ␤-globins, being the two separated portion of the same precursor, must be present in molar ratio 1:1 and the difference observed in the abundance of their MALDI peaks is due to a different ionization yield of the two proteins. The data from all the subjects were converted to ASCII files by using the SpecAlign software, developed by Dr. Jason W. H. Wong, Chemistry Department, Physical and Theoretical Chemistry Laboratory, Oxford University, U.K. The software characteristics have been described elsewhere by Wong et al. [31] ; for the present study, version 1.22b r2 was used. Briefly, the software offers a graphical computational tool that enables simultaneous visualization and manipulation of multiple datasets; data implementation in a matrix suitable for further statistical analysis is easily possible as well as the binning of data according to a specified value; a baseline subtraction tool is also available.
The spectra were pretreated, considering only ionic species with abundance detectable over the background signal. The 15 most intense peaks across all 28 spectra (from 19 patients and nine controls) were tabulated (allowing an uncertainty of Ϯ5 m/z in the peak positions) and their intensities collected into a 15 ϫ 28 matrix. The maximum intensities within each bin were used to represent the intensity noted for that bin. Data processed in ASCII format were imported into an Excel spreadsheet and used for statistical evaluation. Further details on the spectra data handling can be found in the documentation of SpecAlign program [31] .
Multivariate Analysis
Cluster analysis. Cluster analysis is a multivariate procedure of exploratory data analysis for detecting natural groupings in data and examining similarities and dissimilarities between observations. The pattern of globin glycoxidation products in patients and controls was analyzed by using a clustering procedure without any prior knowledge of grouping (unsupervised clustering) to find criteria useful in differentiating between the cases. Data were analyzed using AMADA software [32] using the K-means partition algorithm proposed by J. Hartigan [33] , which splits a set of data into a selected number of groups by minimizing the sum of the squares of the distances between the data and the corresponding cluster centroid (average of the cluster members' coordinates). K-means is a clustering technique that works well if compared to hierarchical methods, and is less affected by outliers; the algorithm classifies data based on their features into k number of groups, k being a positive integer. The distances were measured with Spearman's rank correlation coefficient or Euclidean distance. In some cases, data dimensionality was reduced by correspondence analysis, a statistical ordination method, somewhat similar to principal component analysis (PCA, see below), allowing analysis of large contingency tables [34] .
Principal component analysis (PCA).
PCA is a mathematical procedure that reduces a large set of variables to a small set containing most of the original information. 
Results and Discussion
The typical MALDI spectra of the globin fraction in the range of 15 to 16.4 kDa from a healthy subject and an end-stage renal disease patient are shown in Figure 2a and b, respectively. Some differences can be observed from a visual inspection of the spectra. The two most abundant peaks at m/z 15,126 and 15,866 are due to protonated ␣and ␤-globins, respectively, but a number of other peaks are detectable. Some of them, e.g., those at m/z 15,148 and 15,888, do not represent different molecular species, but derive from Na ϩ cationization of the two globins. The presence of glycated globins is clear, however, from the presence of the related peaks: the ion at m/z 15,288 represents the protonated glycated ␣-globin, while the one at m/z 16,028 is due to protonated glycated ␤-globin. The structural assignments were tentatively done on the basis of observed masses and expectations for the Maillard reaction pattern. Consequently, they must be considered only propositive and the discussion that will follow must be considered in this view. In our opinion, this approach does not seem to compromise the intended diagnostic use of the data because distinctions are valid even if the assignments are uncertain. Further ions may derive from oxidation-dehydration processes occurring on the glycated proteins; e.g., for the ion at m/z 15,223 these processes lead to hydroxymethylfuran. In other words, these ionic species might be consistent with glycated ␣-globin, which -through dehydration and oxidation taking place on the sugar moiety -might leads to hydroxymethylfurane-containing species (Figure 1b) . The tall peak at m/z 15,182 observed in the case of a nephropathic patient (Figure 2b ) might be consistent with the presence of glyoxal-containing species (Figure  1a) . The analogous species is detected for ␤-globin at m/z 15,922. It is worth noting that the patients' spectra have more numerous and more abundant glycoxidated species, suggesting that more oxidation/dehydration might occur on glycated species in kidney disease.
The critical evaluation of the differences between MALDI spectra of ␣and ␤-globins present in blood samples of healthy subjects and patients is a quite difficult task and consequently a multivariate analysis of the data were considered of interest.
The MALDI data of all healthy and nephropathic subjects were processed by multivariate analysis using two different approaches: one considered all species detected in the spectra, while the other excluded the data pertaining to unglycated or simply glycated ␣and ␤-globins. When the k-means clustering algorithm was applied to the spectra according to two grouping criteria, a clear differentiation between patients and controls was obtained for both including (Figure 3 ) and excluding (data not shown) glycated and unglycated ␣and . K-means cluster analysis of all species (after reducing data dimensionality with correspondence analysis) in the MALDI spectra of nephropathic patients (numbered as p1 to p19) and healthy controls (numbered as c1 to c9). The k number of clusters was set to 2 and Euclidean distance was used for metering. A similar grouping was also achieved with the spectra without glycated and unglycated ␣and ␤-globins. ␤-globins. Using three grouping criteria on all the spectral data, the algorithm again presented one compact cluster containing all the controls, and the patients divided unevenly between the other two clusters, regardless of whether or not the data included glycated and unglycated ␣and ␤-globins (data not shown). Extending the grouping criteria to four clusters applied to the whole spectra (Figure 4a ) bundled the data of the controls into a single group, while the data of the patients were distributed among the other three clusters. After excluding the values for glycated and unglycated ␣and ␤-globins, the clustering algorithm according to four grouping criteria led to a split in both the controls' and the patients' data ( Figure 4b) .
The results of the clustering procedure indicate that the MALDI pattern of the spectra can clearly differentiate patients from controls. As suggested by the cluster dendrogram obtained including peaks attributed to glycated and unglycated ␣and ␤-globins (Figure 3) , the contribution of these species in the spectrum appeared to have little diagnostic value in discriminating healthy subjects from nephropathic patients, whereas the pool of glycoxidated species can make this distinction.
Honing the clustering criteria, further differences relating to the glycoxidation products emerge in the patients' data that might be related to the severity of their disease and/or their reactive status. Excluding glycated and unglycated ␣and ␤-globins from the cluster analysis made the patient group more homogenous, suggesting that the behavior of the globins helps to distinguish between patients, but not to separate patients from controls.
PCA confirmed the grouping of patients and controls. The 3D plots of the first three principal components are shown in Figure 5 and Figure 6 . When all the species of the MALDI spectra are considered, the patients' data were quite scattered ( Figure 5 ), but clearly distinguishable from the control group. Excluding the glycated and unglycated globins, the patients' data were more concentrated in a specific region of the principal component space ( Figure 6 ). It is worth noting that the controls were well grouped in both analytical conditions, irrespective of the glycated and unglycated ␣and ␤-globins. The first three components of PCA explained as much as 78% of the total variance among the data, when excluding the globin species, and 71% when including also globin species.
It is worth noting that these procedures are unsupervised, i.e., they are left free to find an aggregating criterion just on the general behavior of the native data; the results obtained, therefore, support the existence of a real capacity of the spectra to differentiate between pathological and healthy conditions.
In conclusion, the multivariate analysis used here proved capable of identifying differential aspects of the profile of ionic species from globins of end-stage nephropathic patients. The point to make is that a correct grouping can be achieved even excluding the glycated and unglycated ␣and ␤-globins, as confirmed by PCA as well as cluster analysis. Our data are also consistent with those of Antolini et al. [23] , who suggested that PCA on oxidative stress parameters can discriminate between hemodialysis patients, transplanted patients, and controls. Our findings suggest that several products involved in the carbonyl stress are present in nephropathic patients, and that these compounds may have a relevant role as specific markers of the disease, even though they are detectable in low amounts.
